FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334163903> ?p ?o ?g. }

• W2334163903 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILProgression risk from early stage localized prostate cancer (CaP) to more aggressive and lethal phenotypes is not precisely predicted. This leads to the over-treatment of men whose disease might otherwise remain indolent. Tumor and serum microRNA (miR) expression show promise as functional biomarkers of CaP progression risk but considerable ambiguity exists over which miR are altered, in which direction and at what point in disease. To address these ambiguities we undertook a genome-wide miR expression comparison using a micro-array approach in key and isogenic CaP cell lines and non-malignant controls. Specifically, cell pairs that represent; Initiation (non-malignant RWPE-1 and RAS-transformed RWPE-2 cells); Progression (non-malignant HPr-1AR and LNCaP cells); Recurrence (LNCaP and LNCaP-C4-2 cells). Comparison between these cell line pairs identified 56 altered miR (≥1.5 fold, p<0.05). Specifically, 11 were altered in Initiation (2 down and 9 up-regulated), 43 in Progression (33 down and 10 up-regulated) and 19 in Recurrence (3 down and 16 up-regulated). Technical validation by Q-PCR supported these findings, as did biological validation in a test-set of 36 locally confined CaP tumors and matched normal pairs. Q-PCR analyses in a longitudinal tumor series from the murine CaP TRAMP model revealed that the expression of murine homologs of several miR (e.g. miR-138 and 205) was significantly altered prior to animals displaying palpable tumors. These findings supported further their utility as early stage disease markers. Importantly, biological validation included analyses in a publically available micro-array data-base of miR from 78 human locally tumors (cBio Cancer Genomics Portal). Approximately 800 miR were in common between the two micro-array platforms and 46, of the 56 miR identified in our cell line studies, were very significantly altered in these primary tumors. Enrichment analysis identified the TGF-β pathway as a key miR-targeted network and supported enhanced TGF-β signaling in the CaP cell lines. To test the ability of miR to discern disease risk at early stage we investigated the expression and association of the 56 miR identified above, with the 24 month risk of biochemical progression following radical prostatectomy, using a cohort of men who had surgery at RPCI. We measured expression of the 56 miR by Q-PCR in 33 men who displayed biochemically progression and 67 non-progressed CaP control patients. Samples were matched on age, PSA levels and Gleason score. We are now establishing the association of individual and multiple serum miR expression at baseline with stage, grade, pre-surgery PSA levels and risk of progression. In parallel we measured the expression of the 56 miR in the tumors of 32 men within this cohort, to measure tumor serum correlations. These analyses will determine the serum miR expression that best differentiate i) men by CaP prognostic variables and ii) who experience biochemical progression.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-477. doi:1538-7445.AM2012-LB-477" @default.
• W2334163903 created "2016-06-24" @default.
• W2334163903 creator A5004959346 @default.
• W2334163903 creator A5013726700 @default.
• W2334163903 creator A5014295844 @default.
• W2334163903 creator A5026373258 @default.
• W2334163903 creator A5056585446 @default.
• W2334163903 creator A5065161783 @default.
• W2334163903 creator A5084842689 @default.
• W2334163903 date "2012-04-15" @default.
• W2334163903 modified "2023-09-27" @default.
• W2334163903 title "Abstract LB-477: Micro-RNA expression patterns to classify prostate cancer risk" @default.
• W2334163903 doi "https://doi.org/10.1158/1538-7445.am2012-lb-477" @default.
• W2334163903 hasPublicationYear "2012" @default.
• W2334163903 type Work @default.
• W2334163903 sameAs 2334163903 @default.
• W2334163903 citedByCount "0" @default.
• W2334163903 crossrefType "proceedings-article" @default.
• W2334163903 hasAuthorship W2334163903A5004959346 @default.
• W2334163903 hasAuthorship W2334163903A5013726700 @default.
• W2334163903 hasAuthorship W2334163903A5014295844 @default.
• W2334163903 hasAuthorship W2334163903A5026373258 @default.
• W2334163903 hasAuthorship W2334163903A5056585446 @default.
• W2334163903 hasAuthorship W2334163903A5065161783 @default.
• W2334163903 hasAuthorship W2334163903A5084842689 @default.
• W2334163903 hasConcept C104317684 @default.
• W2334163903 hasConcept C121608353 @default.
• W2334163903 hasConcept C126322002 @default.
• W2334163903 hasConcept C127716648 @default.
• W2334163903 hasConcept C142724271 @default.
• W2334163903 hasConcept C145059251 @default.
• W2334163903 hasConcept C2779134260 @default.
• W2334163903 hasConcept C2779256057 @default.
• W2334163903 hasConcept C2779723316 @default.
• W2334163903 hasConcept C2780192828 @default.
• W2334163903 hasConcept C502942594 @default.
• W2334163903 hasConcept C54355233 @default.
• W2334163903 hasConcept C71924100 @default.
• W2334163903 hasConcept C86803240 @default.
• W2334163903 hasConceptScore W2334163903C104317684 @default.
• W2334163903 hasConceptScore W2334163903C121608353 @default.
• W2334163903 hasConceptScore W2334163903C126322002 @default.
• W2334163903 hasConceptScore W2334163903C127716648 @default.
• W2334163903 hasConceptScore W2334163903C142724271 @default.
• W2334163903 hasConceptScore W2334163903C145059251 @default.
• W2334163903 hasConceptScore W2334163903C2779134260 @default.
• W2334163903 hasConceptScore W2334163903C2779256057 @default.
• W2334163903 hasConceptScore W2334163903C2779723316 @default.
• W2334163903 hasConceptScore W2334163903C2780192828 @default.
• W2334163903 hasConceptScore W2334163903C502942594 @default.
• W2334163903 hasConceptScore W2334163903C54355233 @default.
• W2334163903 hasConceptScore W2334163903C71924100 @default.
• W2334163903 hasConceptScore W2334163903C86803240 @default.
• W2334163903 hasLocation W23341639031 @default.
• W2334163903 hasOpenAccess W2334163903 @default.
• W2334163903 hasPrimaryLocation W23341639031 @default.
• W2334163903 hasRelatedWork W1964349803 @default.
• W2334163903 hasRelatedWork W2049665105 @default.
• W2334163903 hasRelatedWork W2052471878 @default.
• W2334163903 hasRelatedWork W2313100117 @default.
• W2334163903 hasRelatedWork W2325128532 @default.
• W2334163903 hasRelatedWork W2341571169 @default.
• W2334163903 hasRelatedWork W2415397058 @default.
• W2334163903 hasRelatedWork W2566465501 @default.
• W2334163903 hasRelatedWork W2792494824 @default.
• W2334163903 hasRelatedWork W2890255088 @default.
• W2334163903 hasRelatedWork W2909837257 @default.
• W2334163903 hasRelatedWork W2954165784 @default.
• W2334163903 hasRelatedWork W2955663319 @default.
• W2334163903 hasRelatedWork W2980316773 @default.
• W2334163903 hasRelatedWork W2980397102 @default.
• W2334163903 hasRelatedWork W3013650706 @default.
• W2334163903 hasRelatedWork W3016044873 @default.
• W2334163903 hasRelatedWork W3187167733 @default.
• W2334163903 hasRelatedWork W3199529480 @default.
• W2334163903 hasRelatedWork W3212868907 @default.
• W2334163903 isParatext "false" @default.
• W2334163903 isRetracted "false" @default.
• W2334163903 magId "2334163903" @default.
• W2334163903 workType "article" @default.